162 related articles for article (PubMed ID: 28705838)
1. Leukofiltration plus pathogen reduction prevents alloimmune platelet refractoriness in a dog transfusion model.
Slichter SJ; Pellham E; Bailey SL; Christoffel T; Gettinger I; Gaur L; Latchman Y; Nelson K; Bolgiano D
Blood; 2017 Aug; 130(8):1052-1061. PubMed ID: 28705838
[TBL] [Abstract][Full Text] [Related]
2. Further studies to evaluate methods of leucoreduction to prevent alloimmune platelet refractoriness and induce tolerance in a dog platelet transfusion model.
Slichter SJ; Abrams K; Bailey SL; Pellham E; Gettinger I; Christoffel T; Gaur L; Latchman Y; Nelson K; Bolgiano D
Vox Sang; 2016 Jul; 111(1):62-70. PubMed ID: 27007858
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of different methods of leukoreduction of donor platelets to prevent alloimmune platelet refractoriness and induce tolerance in a canine transfusion model.
Slichter SJ; Fish D; Abrams VK; Gaur L; Nelson K; Bolgiano D
Blood; 2005 Jan; 105(2):847-54. PubMed ID: 15231575
[TBL] [Abstract][Full Text] [Related]
4. Pathogen reduction with amotosalen/UVA reduces platelet refractoriness in a dog platelet transfusion model.
Slichter SJ; Bailey SL; Gettinger I; Pellham E; Christoffel T; Castro G; Green JM; Stassinopoulos A
Vox Sang; 2019 Aug; 114(6):595-604. PubMed ID: 31297836
[TBL] [Abstract][Full Text] [Related]
5. Ultraviolet B irradiation in the prevention of alloimmunization in a dog platelet transfusion model.
Slichter SJ; Abrams K; Gettinger I; Christoffel T; Gaur L; Latchman Y; Nelson K; Pellham E; Bailey SL; Bolgiano D
Transfusion; 2016 Jun; 56(6):1340-7. PubMed ID: 27184061
[TBL] [Abstract][Full Text] [Related]
6. Canine platelet alloimmunization: the role of donor selection.
Slichter SJ; O'Donnell MR; Weiden PL; Storb R; Schroeder ML
Br J Haematol; 1986 Aug; 63(4):713-27. PubMed ID: 3730294
[TBL] [Abstract][Full Text] [Related]
7. Prevention of platelet alloimmunization in dogs with systemic cyclosporine and by UV-irradiation or cyclosporine-loading of donor platelets.
Slichter SJ; Deeg HJ; Kennedy MS
Blood; 1987 Feb; 69(2):414-8. PubMed ID: 3801661
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of the enzyme purine nucleoside phosphorylase (PNP) reduces refractoriness to transfused platelets in a dog model.
Slichter SJ; Deeg HJ; Osborne WR
Br J Haematol; 1990 Aug; 75(4):591-7. PubMed ID: 2119794
[TBL] [Abstract][Full Text] [Related]
9. Platelet transfusions irradiated with ultraviolet-B light may have a role in reducing recipient alloimmunization.
Tandy NP; Pamphilon DH
Blood Coagul Fibrinolysis; 1991 Apr; 2(2):383-8. PubMed ID: 1893070
[TBL] [Abstract][Full Text] [Related]
10. Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions.
Trial to Reduce Alloimmunization to Platelets Study Group
N Engl J Med; 1997 Dec; 337(26):1861-9. PubMed ID: 9417523
[TBL] [Abstract][Full Text] [Related]
11. Alloimmunization against the MHC antigens after platelet transfusions is due to contaminating leukocytes in the platelet suspension.
Claas FH; Smeenk RJ; Schmidt R; van Steenbrugge GJ; Eernisse JG
Exp Hematol; 1981 Jan; 9(1):84-9. PubMed ID: 7238645
[TBL] [Abstract][Full Text] [Related]
12. Leukocyte depletion of random single-donor platelet transfusions does not prevent secondary human leukocyte antigen-alloimmunization and refractoriness: a randomized prospective study.
Sintnicolaas K; van Marwijk Kooij M; van Prooijen HC; van Dijk BA; van Putten WL; Claas FH; Novotny VM; Brand A
Blood; 1995 Feb; 85(3):824-8. PubMed ID: 7833483
[TBL] [Abstract][Full Text] [Related]
13. Determination
Thuku NW; Shikuku K; Mbugua A
Pan Afr Med J; 2017; 27():226. PubMed ID: 28979628
[TBL] [Abstract][Full Text] [Related]
14. Clinical aspects of platelet transfusions.
Murphy MF; Waters AH
Blood Coagul Fibrinolysis; 1991 Apr; 2(2):389-96. PubMed ID: 1893071
[TBL] [Abstract][Full Text] [Related]
15. Storage-Induced Platelet Apoptosis Is a Potential Risk Factor for Alloimmunization Upon Platelet Transfusion.
Saris A; Peyron I; van der Meer PF; Stuge TB; Zwaginga JJ; van Ham SM; Ten Brinke A
Front Immunol; 2018; 9():1251. PubMed ID: 29951051
[TBL] [Abstract][Full Text] [Related]
16. Prevention of platelet alloimmunization.
Slichter SJ
Prog Clin Biol Res; 1986; 211():83-116. PubMed ID: 3515365
[TBL] [Abstract][Full Text] [Related]
17. Platelet refractoriness and alloimmunization.
Slichter SJ
Leukemia; 1998 Sep; 12 Suppl 1():S51-3. PubMed ID: 9777897
[TBL] [Abstract][Full Text] [Related]
18. Pathogen-reduced platelets for the prevention of bleeding.
Butler C; Doree C; Estcourt LJ; Trivella M; Hopewell S; Brunskill SJ; Stanworth S; Murphy MF
Cochrane Database Syst Rev; 2013 Mar; (3):CD009072. PubMed ID: 23543569
[TBL] [Abstract][Full Text] [Related]
19. Prevention of alloimmunization in patients with acute leukemia by use of white cell-reduced blood components--a randomized trial.
Oksanen K; Kekomäki R; Ruutu T; Koskimies S; Myllylä G
Transfusion; 1991 Sep; 31(7):588-94. PubMed ID: 1891788
[TBL] [Abstract][Full Text] [Related]
20. Use of leukocyte-depleted platelet concentrates for the prevention of refractoriness and primary HLA alloimmunization: a prospective, randomized trial.
van Marwijk Kooy M; van Prooijen HC; Moes M; Bosma-Stants I; Akkerman JW
Blood; 1991 Jan; 77(1):201-5. PubMed ID: 1984797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
